• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根除治疗对C反应蛋白的影响:一项荟萃分析的结果

The effect of eradication on C-reactive protein: results from a meta-analysis.

作者信息

Watanabe Jun, Kotani Kazuhiko

机构信息

Division of Community and Family Medicine, Jichi Medical University, Shimotsuke city, Japan.

出版信息

Arch Med Sci. 2021 Mar 21;18(4):958-964. doi: 10.5114/aoms/130288. eCollection 2022.

DOI:10.5114/aoms/130288
PMID:35832706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9267031/
Abstract

INTRODUCTION

is a bacterium that causes chronic gastroduodenal infection and affects various systemic diseases. An increase in the blood level of C-reactive protein (CRP; a systemic inflammatory marker), at a low-grade chronic inflammation level, is observed in cases of infection. However, the effect of eradication on CRP remains undetermined. Therefore, we aimed to evaluate the circulating CRP levels in eradicated patients through a meta-analysis.

MATERIAL AND METHODS

The PubMed database was searched from its inception to June 2020. Studies that described the CRP levels following eradication were collected. A random-effects meta-analysis was then performed using inverse variance with standardized mean difference.

RESULTS

A total of 10 eligible studies (642 subjects in total) were available. The median age in the studies was 49.9 years. The CRP level was 6.0 (median) mg/l before eradication and 5.8 (median) mg/l after eradication. From the results of the overall meta-analysis, there was found to be a significant reduction in the CRP levels with eradication (standardized mean difference: -0.64; 95% confidence interval: -1.02 to -0.27). The result was not similarly confirmed in a subanalysis of the available randomized controlled trials.

CONCLUSIONS

Weak evidence exists regarding the effects of eradication on CRP levels. Further research is called for.

摘要

引言

[某种细菌名称]是一种可引起慢性胃十二指肠感染并影响多种全身性疾病的细菌。在感染病例中,可观察到在低度慢性炎症水平下,C反应蛋白(CRP;一种全身性炎症标志物)的血液水平会升高。然而,根除[细菌名称]对CRP的影响仍未确定。因此,我们旨在通过荟萃分析评估根除[细菌名称]的患者的循环CRP水平。

材料与方法

检索了从PubMed数据库建立至2020年6月的文献。收集了描述根除[细菌名称]后CRP水平的研究。然后使用逆方差和标准化均差进行随机效应荟萃分析。

结果

共有10项符合条件的研究(共642名受试者)。这些研究中的中位年龄为49.9岁。根除[细菌名称]前CRP水平中位数为6.0mg/l,根除后为5.8mg/l。从总体荟萃分析结果来看,根除[细菌名称]后CRP水平有显著降低(标准化均差:-0.64;95%置信区间:-1.02至-0.27)。在现有随机对照试验的亚分析中未得到类似的证实结果。

结论

关于根除[细菌名称]对CRP水平的影响,证据不足。需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a433/9267031/4a4cc8433ac0/AMS-18-4-130288-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a433/9267031/9b9cad795a94/AMS-18-4-130288-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a433/9267031/6f2b604aba7a/AMS-18-4-130288-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a433/9267031/4a4cc8433ac0/AMS-18-4-130288-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a433/9267031/9b9cad795a94/AMS-18-4-130288-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a433/9267031/6f2b604aba7a/AMS-18-4-130288-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a433/9267031/4a4cc8433ac0/AMS-18-4-130288-g003.jpg

相似文献

1
The effect of eradication on C-reactive protein: results from a meta-analysis.根除治疗对C反应蛋白的影响:一项荟萃分析的结果
Arch Med Sci. 2021 Mar 21;18(4):958-964. doi: 10.5114/aoms/130288. eCollection 2022.
2
The Effect of Eradication on Lipid Levels: A Meta-Analysis.根除治疗对血脂水平的影响:一项荟萃分析。
J Clin Med. 2021 Feb 25;10(5):904. doi: 10.3390/jcm10050904.
3
The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels.幽门螺杆菌根除对巨噬细胞移动抑制因子、C 反应蛋白和胎球蛋白 A 水平的影响。
Clinics (Sao Paulo). 2010 Jun;65(8):799-802. doi: 10.1590/s1807-59322010000800010.
4
Effect of enhanced patient instructions on Helicobacter pylori eradication: A systematic review and meta-analysis of randomized controlled trials.增强患者指导对幽门螺杆菌根除效果的影响:一项系统评价和随机对照试验的荟萃分析。
Helicobacter. 2022 Apr;27(2):e12869. doi: 10.1111/hel.12869. Epub 2022 Feb 18.
5
Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.补充益生菌治疗幽门螺杆菌根除的疗效:一项随机对照试验的荟萃分析。
PLoS One. 2016 Oct 10;11(10):e0163743. doi: 10.1371/journal.pone.0163743. eCollection 2016.
6
Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection.牙周治疗作为胃幽门螺杆菌感染的辅助治疗
Cochrane Database Syst Rev. 2016 Feb 7;2(2):CD009477. doi: 10.1002/14651858.CD009477.pub2.
7
compared with placebo as an adjuvant in eradication therapy: a meta-analysis of randomized controlled trials.与安慰剂作为根除治疗辅助剂的比较:随机对照试验的荟萃分析。
Therap Adv Gastroenterol. 2024 Jun 5;17:17562848241258021. doi: 10.1177/17562848241258021. eCollection 2024.
8
Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.幽门螺杆菌(H. pylori)感染与冠状动脉疾病:经皮冠状动脉腔内血管成形术后幽门螺杆菌根除对冠状动脉管腔的影响。人冠状动脉粥样硬化斑块中幽门螺杆菌特异性DNA的检测。
J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31.
9
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.幽门螺杆菌根除与胃癌发病率的关系:系统评价和荟萃分析。
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.
10
Vitamins and : An Updated Comprehensive Meta-Analysis and Systematic Review.维生素与:一项更新的综合荟萃分析和系统评价。 (原文中“and”后面似乎缺失了内容)
Front Nutr. 2022 Jan 18;8:781333. doi: 10.3389/fnut.2021.781333. eCollection 2021.

引用本文的文献

1
Helicobacter pylori in the Philippines: Social and Ecological Determinants of Seropositivity and Lack of Association With Systemic Inflammation.菲律宾的幽门螺杆菌:血清阳性的社会和生态决定因素以及与全身炎症缺乏关联
Am J Hum Biol. 2025 May;37(5):e70069. doi: 10.1002/ajhb.70069.
2
Serum high sensitive C-reactive protein level and its correlation with lipid profile among dyspeptic patients with or without infection in East Gojjam zone, Ethiopia.埃塞俄比亚东戈贾姆地区消化不良患者(无论有无感染)的血清高敏C反应蛋白水平及其与血脂谱的相关性
Front Cardiovasc Med. 2024 Sep 26;11:1470993. doi: 10.3389/fcvm.2024.1470993. eCollection 2024.
3

本文引用的文献

1
Evaluation of atherogenic laboratory markers in Behçet's disease patients with vascular involvement.白塞病血管受累患者动脉粥样硬化实验室标志物的评估。
Arch Med Sci. 2019 Oct 27;16(3):531-537. doi: 10.5114/aoms.2018.79139. eCollection 2020.
2
as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study.作为肝硬化患者并发症的起始因素:一项单中心观察性研究
Front Med (Lausanne). 2020 Mar 24;7:96. doi: 10.3389/fmed.2020.00096. eCollection 2020.
3
Effect of Helicobacter pylori infection on the risk of acute coronary syndrome: A systematic review and meta-analysis.
The association between Helicobacter pylori infection and the risk for gout in hyperuricemia patients in China - A cross-sectional study.
中国高尿酸血症患者中幽门螺杆菌感染与痛风风险的关联——一项横断面研究。
Gut Pathog. 2024 Apr 27;16(1):24. doi: 10.1186/s13099-024-00615-x.
4
The causal effect of Helicobacter pylori infection on coronary heart disease is mediated by the body mass index: a Mendelian randomization study.幽门螺杆菌感染对冠心病的因果效应是通过体重指数介导的:一项孟德尔随机化研究。
Sci Rep. 2024 Jan 19;14(1):1688. doi: 10.1038/s41598-024-51701-8.
幽门螺杆菌感染对急性冠状动脉综合征风险的影响:一项系统评价和荟萃分析。
Medicine (Baltimore). 2019 Dec;98(50):e18348. doi: 10.1097/MD.0000000000018348.
4
RoB 2: a revised tool for assessing risk of bias in randomised trials.《随机对照试验偏倚风险评估工具2:修订版》
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
5
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.英国胃肠病学会关于胃腺癌风险患者的诊断和管理指南。
Gut. 2019 Sep;68(9):1545-1575. doi: 10.1136/gutjnl-2018-318126. Epub 2019 Jul 5.
6
Nutritional interventions for preventing stunting in children (birth to 59 months) living in urban slums in low- and middle-income countries (LMIC).针对低收入和中等收入国家(LMIC)城市贫民窟中出生至59个月大儿童预防发育迟缓的营养干预措施。
Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD011695. doi: 10.1002/14651858.CD011695.pub2.
7
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.日本幽门螺杆菌感染管理指南:2016 年修订版。
Helicobacter. 2019 Aug;24(4):e12597. doi: 10.1111/hel.12597. Epub 2019 May 20.
8
Eradication Treatment Alters Gut Microbiota and GLP-1 Secretion in Humans.根除治疗改变人体肠道微生物群和胰高血糖素样肽-1分泌。
J Clin Med. 2019 Apr 4;8(4):451. doi: 10.3390/jcm8040451.
9
Helicobacter: Inflammation, immunology, and vaccines.幽门螺杆菌:炎症、免疫学和疫苗。
Helicobacter. 2018 Sep;23 Suppl 1(Suppl 1):e12517. doi: 10.1111/hel.12517.
10
Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma?幽门螺杆菌与非酒精性脂肪性肝病:新的谜团?
Helicobacter. 2018 Dec;23(6):e12537. doi: 10.1111/hel.12537. Epub 2018 Sep 23.